Efficacy and Safety of Cetagliptin Therapy as Monotherapy in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
Diabetes Obes Metab 2023 Sep 03;[EPub Ahead of Print], L Ji, J Lu, L Gao, C Ying, J Sun, J Han, W Zhao, Y Gao, K Wang, X Zheng, D Xie, J Ding, J Zhao, Q Yu, T WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.